A-share companies are swiftly intensifying their Hong Kong listing endeavors, with a remarkable 10 companies already successfully debuting on the Hong Kong Stock Exchange this year, while another 78 companies are actively preparing or have submitted their listing applications. Industry giants like Hengrui Medicine and CATL are vigorously expanding their presence in the Hong Kong stock market, a movement fueled by policy backing, globalization strategies, and robust financing requirements.

The Hong Kong stock market, intrinsically tied to international capital, offers enterprises a more agile fund operational environment. Furthermore, IPOs in Hong Kong have garnered substantial interest from numerous foreign institutions, gradually narrowing the AH premium rate. In certain instances, Hong Kong stocks have even seen premium issuances, signifying a profound transformation in the market's structural landscape.

Emerging sectors like technology and new energy are increasingly dominating the Hong Kong stock market, exhibiting enhanced valuation appeal. It is anticipated that the Hong Kong stock market will witness a significant influx of capital in the foreseeable future.